DPhil research opportunities 2022
Applications for the DPhil in Medical Sciences for entry in October 2022 are now open. Further research opportunities may be added to this list over the next few weeks.
| Title | |
|---|---|
| Chakraverty Group - Immunotherapy Chakraverty Group - Immunotherapy | Ronjon Chakraverty |
| Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: From novel imaging biomarkers development to drug target discovery Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: From novel imaging biomarkers development to drug target discovery | Charalambos Antoniades |
| Bhattacharya Group - Therapeutic targeting of chemokines in inflammation Bhattacharya Group - Therapeutic targeting of chemokines in inflammation | Shoumo Bhattacharya |
| Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes from CAD GWAS loci using in vitro and in vivo models Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes from CAD GWAS loci using in vitro and in vivo models | Gillian Douglas |
| Choudhury Group - Innate immune function in atherosclerosis and acute myocardial infarction Choudhury Group - Innate immune function in atherosclerosis and acute myocardial infarction | Robin Choudhury |
| Karpe Group - Human fat distribution and metabolic disease Karpe Group - Human fat distribution and metabolic disease | Fredrik Karpe |
| Kerr-Cai Group - Epigenetic regulation of cholangiocarcinoma growth Kerr-Cai Group - Epigenetic regulation of cholangiocarcinoma growth | David Kerr |
| Leeson Group - Imaging in Preventive Cardiology Research Leeson Group - Imaging in Preventive Cardiology Research | Paul Leeson |
| Lygate Group - Realising the therapeutic potential of creatine and homoarginine in heart disease Lygate Group - Realising the therapeutic potential of creatine and homoarginine in heart disease | Craig Lygate |
| Piechnik Group - Myocardial functional T1 mapping – Advanced cardiac magnetic resonance imaging techniques Piechnik Group - Myocardial functional T1 mapping – Advanced cardiac magnetic resonance imaging techniques | Stefan Piechnik |
| Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation | Svetlana Reilly |
| Tzima Group - Go with the flow---the why and how of cardiovascular disease Tzima Group - Go with the flow---the why and how of cardiovascular disease | Ellie Tzima |
| Watkins Group – Genetics of inherited cardiovascular disease Watkins Group – Genetics of inherited cardiovascular disease | Hugh Watkins |
| Drakesmith Group - Iron Biology Drakesmith Group - Iron Biology | Hal Drakesmith |
| Goriely Group - De Novo Mutations and Human Disease Goriely Group - De Novo Mutations and Human Disease | Anne Goriely |
| Higgs Group - Laboratory of Gene Regulation Higgs Group - Laboratory of Gene Regulation | Douglas Higgs |
| Mead Group - Unravelling mechanisms of disease progression in Myeloproliferative Neoplasms Mead Group - Unravelling mechanisms of disease progression in Myeloproliferative Neoplasms | Adam Mead |
| Vyas Group - Normal and leukaemic stem/progenitor cell biology and immune responses to blood cancer cells. Vyas Group - Normal and leukaemic stem/progenitor cell biology and immune responses to blood cancer cells. | Paresh Vyas |
| Wilkie Group - Building the skull – normal and abnormal development Wilkie Group - Building the skull – normal and abnormal development | Andrew Wilkie |
| Nerlov Group - Hematopoietic Stem Cell Genetics Nerlov Group - Hematopoietic Stem Cell Genetics | Claus Nerlov |
| Patel Group - Origins of Genotoxic metabolism and the DNA damage response in stem and cancer cells Patel Group - Origins of Genotoxic metabolism and the DNA damage response in stem and cancer cells | KJ Patel |
| Rorsman Group - Preferential Gq signalling in diabetes: an electrical switch in incretin action and in diabetes progression? Rorsman Group - Preferential Gq signalling in diabetes: an electrical switch in incretin action and in diabetes progression? | Patrik Rorsman |
| Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9. Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9. | Christopher Toepfer |
| Christodoulides Group– Deciphering the role of white and brown adipocytes in metabolic disease. Christodoulides Group– Deciphering the role of white and brown adipocytes in metabolic disease. | Constantinos Christodoulides |
| Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints | Simon Davis |
| Chapman Group - Genome Diversification in Cancer and Adaptive Immunity Chapman Group - Genome Diversification in Cancer and Adaptive Immunity | Ross Chapman |
| David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues | |
| Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy | Ladislav Valkovic |